Mesenchymal stem cell-based FGF2 gene therapy for acute lung injury induced by lipopolysaccharide in mice

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 5, 2015, Pages 857-865

  Zhao, Y F ^a   Luo, Y M ^b   Xiong, W ^a   Ding, W ^a   Li, Y R ^a   Zhao, W ^a   Zeng, H Z ^a   Gao, H C ^a   Wu, X L ^c  

^a Gongli Hospital   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow derived mesenchymal stem cells; Fibroblast growth factor; Gene therapy; LPS induced lung injury

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; LENTIVIRUS VECTOR; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONOTHERAPY; MOUSE; NONHUMAN; STEM CELL GENE THERAPY; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; GENE THERAPY; GENETICS; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; RANDOMIZATION;

ACUTE LUNG INJURY; ANIMALS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENETIC THERAPY; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION;

EID: 84942258876     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MATTHAY MA, ZEMANS RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011;6:147-163.
2. WARE LB, MATTHAY MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
3. ZAMBON M, VINCENT JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008;133:1120-1127.
4. WILCOX ME, HERRIDGE MS. Long-term outcomes in patients surviving acute respiratory distress syndrome. Semin Respir Crit Care Med 2010;31:55-65.
5. MATTHAY MA, GOOLAERTS A, HOWARD JP, LEE JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med 2010;38:S569-573.
6. CRIBBS SK, MATTHAY MA, MARTIN GS. Stem cells in sepsis and acute lung injury. Crit Care Med 2010;38:2379-2385.
7. LEE JW, GUPTA N, SERIKOV V, MATTHAY MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009;9:1259-1270.
8. KRASNODEMBSKAYA A, SONG Y, FANG X, GUPTA N, SERIKOV V, LEE JW, MATTHAY MA. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010;28:2229-2938.
9. MEI SH, HAITSMA JJ, DOS SANTOS CC, DENG Y, LAI PF, SLUTSKY AS, LILES WC, STEWART DJ. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010;182:1047-1057.
10. PROCKOP DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
11. PITTENGER MF, MACKAY AM, BECK SC, JAISWAL RK, DOUGLAS R, MOSCA JD, MOORMAN MA, SIMONETTI DW, CRAIG S, MARSHAK DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
12. PROCKOP DJ, GREGORY CA, SPEES JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci 2003;100:11917-11923.
13. KIM HS. Assignment1 of the human basic fibroblast growth factor gene FGF2 to chromosome 4 band q26 by radiation hybrid mapping. Cytogenet Cell Genet 1998;83:73.
14. BASILICO C, MOSCATELLI D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-165.
15. ECKLE T, FULLBIER L, WEHRMANN M, KHOURY J, MITTELBRONN M, IBLA J, ROSENBERGER P, ELTZSCHIG HK. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007;178:8127-8137.
16. DOMINICI M, LE BLANC K, MUELLER I, SLAPER-CORTENBACH I, MARINI F, KRAUSE D, DEANS R, KEATING A, PROCKOP D, HORWITZ E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
17. ANJOS-AFONSO F, SIAPATI EK, BONNET D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004;117:5655-5664.
18. PEISTER A, MELLAD JA, LARSON BL, HALL BM, GIBSON LF, PROCKOP DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
19. TANGHETTI E, RIA R, DELL'ERA P, URBINATI C, RUSNATI M, ENNAS MG, PRESTA M. Biological activity of substratebound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. Oncogene 2002;21:3889-3897.
20. FEI Y, GRONOWICZ G, HURLEY MM. Fibroblast growth factor-2, bone homeostasis and fracture repair. Curr Pharm Des 2013;19:3354-3363.
21. WOODBURY ME, IKEZU T. Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol 2014;9:92-101.
22. ITOH N, OHTA H. Pathophysiological roles of FGF signaling in the heart. Front Physiol 2013;4:247.
23. DIECKE S, QUIROGA-NEGREIRA A, REDMER T, BESSER D. FGF2 signaling in mouse embryonic fibroblasts is crucial for self-renewal of embryonic stem cells. Cells Tissues Organs 2008;188:52-61.
24. VAN HAAFTEN T, BYRNE R, BONNET S, ROCHEFORT GY, AKABUTU J, BOUCHENTOUF M, REY-PARRA GJ, GALIPEAU J, HAROMY A, EATON F, CHEN M, HASHIMOTO K, ABLEY D, KORBUTT G, ARCHER SL, THEBAUD B. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009;180:1131-1142.
25. ASLAM M, BAVEJA R, LIANG OD, FERNANDEZ-GONZALEZ A, LEE C, MITSIALIS SA, KOUREMBANAS S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009;180:1122-1130.
26. ORTIZ LA, GAMBELLI F, MCBRIDE C, GAUPP D, BADDOO M, KAMINSKI N, PHINNEY DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci 2003;100:8407-8411.
27. ROJAS M, XU J, WOODS CR, MORA AL, SPEARS W, ROMAN J, BRIGHAM KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
28. MAILLOUX AW, ZHANG L, MOSCINSKI L, BENNETT JM, YANG L, YODER SJ, BLOOM G, WEI C, WEI S, SOKOL L, LOUGHRAN TP, JR., EPLING-BURNETTE PK. Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia. J Immunol 2013;191:3578-3593.
29. ISRASENA N, HU M, FU W, KAN L, KESSLER JA. The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells. Dev Biol 2004;268:220-231.
30. KNELSON EH, GAVIGLIO AL, TEWARI AK, ARMSTRONG MB, MYTHREYE K, BLOBE GC. Type III TGF-beta receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. J Clin Invest 2013;123:4786-4798.
31. DIGHE PA, VISWANATHAN P, MRUTHUNJAYA AK, SEETHARAM RN. Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells. J Stem Cells 2013;8:43-57